These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28110690)

  • 1. Improved cognitive and memory abilities in a patient with Alzheimer's disease treated with activated immune cells: Immune cell therapy may benefit more AD patients.
    Laumbacher B; Fellerhoff-Loesch B; Wank R
    Med Hypotheses; 2017 Feb; 99():19-22. PubMed ID: 28110690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies.
    Liu YH; Zeng F; Wang YR; Zhou HD; Giunta B; Tan J; Wang YJ
    Drug Discov Today; 2013 Dec; 18(23-24):1212-20. PubMed ID: 23954180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: Innate immunity gone awry?
    VanItallie TB
    Metabolism; 2017 Apr; 69S():S41-S49. PubMed ID: 28129888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
    Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
    Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on advances of treatment modalities for Alzheimer's disease.
    Se Thoe E; Fauzi A; Tang YQ; Chamyuang S; Chia AYY
    Life Sci; 2021 Jul; 276():119129. PubMed ID: 33515559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease, brain immune privilege and memory: a hypothesis.
    Arshavsky YI
    J Neural Transm (Vienna); 2006 Nov; 113(11):1697-707. PubMed ID: 16932992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alzheimer's disease as neurodegenerative disorder].
    Zabłocka A
    Postepy Hig Med Dosw (Online); 2006; 60():209-16. PubMed ID: 16641890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment.
    Joubert S; Gour N; Guedj E; Didic M; Guériot C; Koric L; Ranjeva JP; Felician O; Guye M; Ceccaldi M
    Cortex; 2016 Jan; 74():217-32. PubMed ID: 26694580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
    Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
    Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.
    Lueg G; Gross CC; Lohmann H; Johnen A; Kemmling A; Deppe M; Groger J; Minnerup J; Wiendl H; Meuth SG; Duning T
    Neurobiol Aging; 2015 Jan; 36(1):81-9. PubMed ID: 25277040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity and neuronal repair in the progression of Alzheimer's disease: a brief overview.
    Baron R; Harpaz I; Nemirovsky A; Cohen H; Monsonego A
    Exp Gerontol; 2007; 42(1-2):64-9. PubMed ID: 17074458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy of Alzheimer's disease. Results of experimental investigations and treatment of perspectives].
    Karkos J
    Fortschr Neurol Psychiatr; 2004 Apr; 72(4):204-19. PubMed ID: 15095177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-versus late-onset Alzheimer's disease: more than age alone.
    Koedam EL; Lauffer V; van der Vlies AE; van der Flier WM; Scheltens P; Pijnenburg YA
    J Alzheimers Dis; 2010; 19(4):1401-8. PubMed ID: 20061618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation of the brain in Alzheimer's disease: implications for therapy.
    McGeer PL; McGeer EG
    J Leukoc Biol; 1999 Apr; 65(4):409-15. PubMed ID: 10204568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
    Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.
    Wang HC; Yu YZ; Liu S; Zhao M; Xu Q
    Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
    Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapies in Alzheimer's disease: Too much, too little, too late or off-target?
    St-Amour I; Cicchetti F; Calon F
    Acta Neuropathol; 2016 Apr; 131(4):481-504. PubMed ID: 26689922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive rehabilitation in a visual variant of Alzheimer's disease.
    Alves J; Magalhães R; Arantes M; Cruz S; Gonçalves ÓF; Sampaio A
    Appl Neuropsychol Adult; 2015; 22(1):73-8. PubMed ID: 25529594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.